, 2008 FC 1185 (Alendronate*)
Justice Hughes - 2008-10-21
Read full decision. Automatically generated summary:
This is an action brought by the Plaintiff, Apotex Inc., under the provisions of section 8 of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133, as amended (PMNOC Regulations), claiming recovery against the Respondents, Merck Frosst Canada Ltd. and Merck Frosst Canada & Co. (collectively Merck). This is the first such action to proceed to trial on the merits. The parties have raised a number of preliminary issues for determination at this time, leaving the quantification of any award, if required, to a later trial.
Decision relates to:
- T-1144-05 - APOTEX INC. v. MERCK & CO. INC. ET AL.
- A-571-08(2009 FCA 187) - which is an appeal from this decision
- T-1144-05 - APOTEX INC. v. MERCK & CO. INC. ET AL.
- A-580-08(2009 FCA 187) - which is an appeal from this decision